Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,147Revenue (TTM) $M38.1Net Margin (%)--Altman Z-Score--
Enterprise Value $M--EPS (TTM) $-5.1Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M10.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with FURX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
FURXMario Gabelli 2014-06-30 Buy 0.03%$75.24 - $105.3
$ 104.777%New holding54,400
FURXDavid Einhorn 2012-03-31 Sold Out -0.14%$15.83 - $24.64
$ 104.77487%Sold Out0
FURXThird Avenue Management 2010-12-31 Sold Out -0.01%$11.07 - $14.4
$ 104.77738%Sold Out0
FURXThird Avenue Management 2010-09-30 Buy 0.01%$9.42 - $11.94
$ 104.77889%New holding38,789
FURXDavid Einhorn 2010-06-30 Buy 0.15%$9.11 - $11.47
$ 104.77907%New holding490,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

FURX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

FURX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Forest Laboratories, LLC10% Owner 2014-07-02Buy11,169,066$9510.28view
COVINGTON PAUL SSenior VP-Clinical Operations 2014-06-24Sell10,368$104.120.62view
Patel SailashCFO 2014-06-24Sell32,928$1040.74view
COVINGTON PAUL SSenior VP-Clinical Operations 2014-06-18Sell45,691$104.110.63view
McIntyre Gail FrancesSenior Vice President-Research 2014-06-17Sell74,457$105.01-0.23view
COVINGTON PAUL SSenior VP-Clinical Operations 2014-06-13Sell3,228$104.250.5view
COVINGTON PAUL SSenior VP-Clinical Operations 2014-06-10Sell2,872$104.630.13view
McIntyre Gail FrancesSenior Vice President-Research 2014-06-10Sell1,746$104.580.18view
Patel SailashCFO 2014-06-10Sell1,504$104.680.09view
Almenoff June SheriePresident 2014-02-04Sell115,113$115.29-9.12view

Quarterly/Annual Reports about FURX:

    News about FURX:

    Articles On GuruFocus.com
    Pershing Square Gains Board Seat on Valeant Mar 11 2016 

    More From Other Websites
    No related articles found.

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)